US biotech AIRNA has raised $155 million in series B funding to advance its lead RNA-editing therapy into human trials and ...

Family-controlled Spanish pharma company Esteve has signed a license and supply agreement with Eton Pharmaceuticals (Nasdaq: ...

Olga Uspenskaya-Cado has been named chief medical officer (CMO) of VectorY Therapeutics, a privately-held Dutch biotech ...

US drug developer Palatin Technologies (NYSE American: PTN) announced that its BMT-801 Phase II obesity co-administration ...

Positive results from the PURSUIT Phase IIb trial of AstraZeneca’s AZD0780 have shown a statistically significant low-density ...

New data from Israel-based generics giant Teva Pharmaceutical Industries (NYSE: TEVA) show favorable patient and healthcare ...

Merck & Co has announced the first presentation of full results from the Phase III ZENITH trial of Winrevair ...

Eisai (TYO: 4523) and Biogen (Nasdaq: BIIB) today provided an update on the ongoing regulatory review of the Marketing ...

China's Bio-Thera Solutions has entered into an exclusive commercialization agreement with India's Dr. Reddy's Laboratories ...

Japanese drugmaker Nxera Pharma (TYO 4565) today announced two new appointments to its leadership team: Kiyoshi Kaneko, is ...

Eli Lilly (NYSE: LLY) is advancing its ambitions in cardiometabolic medicine with new mid-stage data showing that solbinsiran ...

The European Commission (EC) has issued a decision amending the marketing authorization for Abrysvo, US pharma giant Pfizer’s ...